Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Current treatments for alopecia show no significant long-term benefits.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Alopecia areata treatment varies, with no optimal method established yet.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Some systemic treatments work for nail psoriasis but can have serious side effects.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.